Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD

Galmed Pharmaceuticals (GLMD) Technical Analysis

1,152 Followers

Technical Sentiment

Overall Consensus
Neutral
7Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Galmed Pharmaceuticals’s (GLMD) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Galmed Pharmaceuticals is a Sell.
Galmed Pharmaceuticals’s (GLMD) 20-Day exponential moving average is 0.31, while Galmed Pharmaceuticals’s (GLMD) share price is $0.314, making it a Buy.
Galmed Pharmaceuticals’s (GLMD) 50-Day exponential moving average is 0.33, while Galmed Pharmaceuticals’s (GLMD) share price is $0.314, making it a Sell.

Galmed Pharmaceuticals (GLMD) Pivot Points

Jul 27, 2024, 02:08 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.21
0.24
0.26
0.29
0.32
0.35
0.37
Fibonacci
0.24
0.26
0.27
0.29
0.31
0.33
0.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Galmed Pharmaceuticals (GLMD) Moving Averages

Jul 27, 2024, 02:08 AM
Period
Simple
Exponential
MA5
0.31Sell
0.31Buy
MA10
0.31Buy
0.31Buy
MA20
0.30Buy
0.31Buy
MA50
0.33Sell
0.33Sell
MA100
0.35Sell
0.35Sell
MA200
0.37Sell
0.42Sell
Galmed Pharmaceuticals’s (GLMD) 10-Day exponential moving average is 0.31, while Galmed Pharmaceuticals’s (GLMD) share price is $0.314, making it a Buy.
Galmed Pharmaceuticals’s (GLMD) 100-Day exponential moving average is 0.35, while Galmed Pharmaceuticals’s (GLMD) share price is $0.314, making it a Sell.
Galmed Pharmaceuticals’s (GLMD) stock price is $0.314 and Galmed Pharmaceuticals’s (GLMD) 50-day simple moving average is 0.33, creating a Sell signal.
Galmed Pharmaceuticals’s (GLMD) stock price is $0.314 and Galmed Pharmaceuticals’s (GLMD) 100-day simple moving average is 0.35, creating a Sell signal.
Galmed Pharmaceuticals’s (GLMD) stock price is $0.314 and Galmed Pharmaceuticals’s (GLMD) 200-day simple moving average is 0.37, creating a Sell signal.

Galmed Pharmaceuticals (GLMD) Technical Indicators

Jul 27, 2024, 02:08 AM
Name
Value
Implied Action
RSI (14)
49.13
Neutral
STOCH (9,6)
56.50
Neutral
STOCHRSI (14)
57.16
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
17.83
Buy
Williams %R
-36.62
Buy
CCI (14)
-11.87
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
61.95
Neutral
ROC
0.00
-
Galmed Pharmaceuticals’s (GLMD) Relative Strength Index (RSI) is 49.13, creating a Neutral signal.
Galmed Pharmaceuticals’s (GLMD) Trend Strength Indicator (ADX) is 17.83, creating a Buy signal.
Galmed Pharmaceuticals’s (GLMD) Commodity Channel Index (CCI) is -11.87, creating a Neutral signal.

FAQ

Is GLMD a Buy, Hold, or Sell?
Based on GLMD’s technical indicators, GLMD is a Hold.
    What is GLMD’s RSI (14)?
    GLMD’s RSI (14) is 49.13, which suggests GLMD is a Neutral.
      What is GLMD’s MACD?
      GLMD’s MACD is >-0.01, which suggests GLMD is a Sell.
        What is GLMD’s 5-day moving average?
        GLMD’s 5-day moving average is 0.31, which suggests GLMD is a Sell.
          What is GLMD’s 20-day moving average?
          GLMD 20-day moving average is 0.30, which suggests GLMD is a Buy.
            What is GLMD’s 50-day moving average?
            GLMD’s 50-day moving average is 0.33, which suggests GLMD is a Sell.
              What is GLMD’s 200-day moving average?
              GLMD’s 200-day moving average is 0.37, which suggests GLMD is a Sell.
                What is GLMD’s Williams % R (14)?
                GLMD’s Williams % R (14) is -36.62, which suggests GLMD is a Buy.
                  What is GLMD’s CCI (14)?
                  GLMD’s CCI (14) is -11.87, which suggests GLMD is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis